SI
JAZZ icon

Shaker Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Shaker Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,276
Closed -$324K – 86
2019
Q2 		$324K Buy
2,276
+39
+2% +$5.24K 0.22% 77
2019
Q1 		$320K Buy
2,237
+20
+0.9% +$2.61K 0.22% 71
2018
Q4 		$275K Sell
2,217
-1,715
-44% -$254K 0.24% 58
2018
Q3 		$661K Sell
3,932
-30
-0.8% -$5.16K 0.41% 50
2018
Q2 		$683K Hold
3,962
– – 0.42% 52
2018
Q1 		$598K Sell
3,962
-88
-2% -$12.9K 0.37% 56
2017
Q4 		$545K Sell
4,050
-1,739
-30% -$241K 0.36% 53
2017
Q3 		$847K Buy
5,789
+110
+2% +$16.6K 0.59% 43
2017
Q2 		$883K Buy
+5,679
New +$868K 0.67% 42
2016
Q4 		– Sell
-3,450
Closed -$419K – 71
2016
Q3 		$419K Buy
3,450
+1,450
+73% +$195K 0.34% 58
2016
Q2 		$283K Buy
+2,000
New +$295K 0.26% 62
2016
Q1 		– Sell
-2,140
Closed -$301K – 70
2015
Q4 		$301K Sell
2,140
-1,500
-41% -$208K 0.25% 68
2015
Q3 		$483K Hold
3,640
– – 0.38% 54
2015
Q2 		$641K Hold
3,640
– – 0.45% 50
2015
Q1 		$629K Hold
3,640
– – 0.42% 51
2014
Q4 		$596K Hold
3,640
– – 0.4% 53
2014
Q3 		$584K Buy
+3,640
New +$560K 0.4% 52

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Shaker Investments's JAZZ Position: Q3 2019 in Review

Shaker Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 2,276 shares — an estimated $324K sold.

Shaker Investments first reported a position in JAZZ in Q3 2014 and held it in 17 quarters. The position peaked at $883K in Q2 2017. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Shaker Investments reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Shaker Investments sold 2,276 Jazz Pharmaceuticals shares in Q3 2019, an estimated $324K.
  • Shaker Investments first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 17 quarters.
  • Shaker Investments's Jazz Pharmaceuticals position peaked at $883K in Q2 2017.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Shaker Investments's 13F filing for Q3 2019, filed 28 Oct 2019.